What are the best treatments for Alzheimer's Disease?

TL;DR: Currently, treatments for Alzheimer's disease focus on managing symptoms and slowing disease progression through a combination of pharmacological therapies, such as cholinesterase inhibitors and monoclonal antibodies, alongside lifestyle interventions. Because Alzheimer's disease is a complex, progressive condition, treatment must be highly personalized by a specialist to address the unique cognitive and functional needs of each patient.

What are the primary medications for Alzheimer's disease?

For individuals diagnosed with Alzheimer's disease, clinicians typically prescribe medications to manage cognitive decline. First-line treatments include cholinesterase inhibitors like donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), which help improve communication between nerve cells. For moderate to severe cases, memantine (Namenda) is often used to regulate glutamate activity. Recently, new disease-modifying therapies, such as lecanemab (Leqembi), have been approved for early-stage Alzheimer's disease to target amyloid-beta plaques in the brain.

What non-pharmacological approaches support patients?

Non-pharmacological strategies are vital for maintaining quality of life in those living with Alzheimer's disease. These interventions focus on maximizing independence and reducing behavioral symptoms through:

• Cognitive stimulation therapy: Engaging in structured activities to improve memory and social interaction.


• Occupational therapy: Modifying the home environment to ensure safety and simplify daily tasks.


• Regular physical exercise: Proven to improve mood and mobility, helping to manage the physical decline associated with Alzheimer's disease.


• Caregiver support programs: Essential for managing the psychological burden on families.

Which specialists should be on the care team?

A multidisciplinary approach is the gold standard for managing Alzheimer's disease. A typical care team should include a neurologist or geriatrician for medical management, a neuropsychologist for cognitive testing, an occupational therapist for functional planning, and a social worker to assist with long-term care coordination. With 28 community members currently sharing their experiences on DiseaseMaps.org, we see how integrated care significantly impacts patient outcomes.

Are there emerging treatments in clinical trials?

Research into Alzheimer's disease is rapidly evolving. Current clinical trials are investigating tau-targeting therapies, anti-inflammatory agents, and combination drug regimens aimed at halting neurodegeneration. Patients interested in these experimental options should consult their neurologist to determine if they qualify for specific clinical studies.

Next steps

• Schedule an evaluation with a neurologist or memory disorder specialist.


• Connect with the 28 members of the DiseaseMaps.org Alzheimer's disease community to share experiences and coping strategies.


• Inquire with your care team about active, phase-three clinical trials in your region.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult with your physician regarding specific medical concerns.

References

• National Institute on Aging (NIA) - Alzheimer's Disease Fact Sheet


• NIH Genetic and Rare Diseases Information Center (GARD)


• Alzheimer’s Association (alz.org)


• PubMed: Clinical Guidelines for the Management of Dementia